132 related articles for article (PubMed ID: 30808723)
1. Thalidomide-induced psoriasis in a patient with multiple myeloma.
D'Arena G; Galdo G; Musto P
Postgrad Med J; 2019 Mar; 95(1121):171. PubMed ID: 30808723
[No Abstract] [Full Text] [Related]
2. Psoriasis induced by thalidomide in a patient with multiple myeloma.
Ferrazzi A; Zambello R; Russo I; Alaibac M
BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24973347
[TBL] [Abstract][Full Text] [Related]
3. Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma.
Trojan A; Chasse E; Gay B; Pichert G; Taverna C
Ann Oncol; 2003 Mar; 14(3):501-2. PubMed ID: 12598363
[No Abstract] [Full Text] [Related]
4. Thalidomide in elderly patients with multiple myeloma.
Kusumi E; Matsumura T; Yuji K; Tanaka Y; Kami M
Lancet; 2006 Jun; 367(9527):1977; author reply 1977-8. PubMed ID: 16782479
[No Abstract] [Full Text] [Related]
5. Bradycardia during therapy for multiple myeloma with thalidomide.
Fahdi IE; Gaddam V; Saucedo JF; Kishan CV; Vyas K; Deneke MG; Razek H; Thorn B; Bissett JK; Anaissie EJ; Barlogie B; Mehta JL
Am J Cardiol; 2004 Apr; 93(8):1052-5. PubMed ID: 15081457
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide therapy and polyneuropathy in myeloma patients.
Laaksonen S; Remes K; Koskela K; Voipio-Pulkki LM; Falck B
Electromyogr Clin Neurophysiol; 2005 Mar; 45(2):75-86. PubMed ID: 15861857
[TBL] [Abstract][Full Text] [Related]
7. Exacerbation of psoriasis by thalidomide in Behçet's syndrome.
Dobson CM; Parslew RA
Br J Dermatol; 2003 Aug; 149(2):432-3. PubMed ID: 12932265
[No Abstract] [Full Text] [Related]
8. Desensitization to thalidomide in a patient with multiple myeloma.
Nucera E; Schiavino D; Hohaus S; Leone G; Buonomo A; Lombardo C; Patriarca G
Clin Lymphoma Myeloma; 2008 Jun; 8(3):176-8. PubMed ID: 18650182
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide-induced neuropathy.
Crawford CL
Mayo Clin Proc; 2002 Dec; 77(12):1395; author reply 1395. PubMed ID: 12479531
[No Abstract] [Full Text] [Related]
10. Arterial and venous thrombotic complications with thalidomide in multiple myeloma.
Alkindi S; Dennison D; Pathare A
Arch Med Res; 2008 Feb; 39(2):257-8. PubMed ID: 18164975
[No Abstract] [Full Text] [Related]
11. Thalidomide therapy and deep venous thrombosis in multiple myeloma.
Rajkumar SV
Mayo Clin Proc; 2005 Dec; 80(12):1549-51. PubMed ID: 16350272
[No Abstract] [Full Text] [Related]
12. Exacerbation of psoriasis by thalidomide in a patient with erythema multiforme.
Varma K; Finlay AY
Br J Dermatol; 2006 Apr; 154(4):789-90. PubMed ID: 16536837
[No Abstract] [Full Text] [Related]
13. Thalidomide in multiple myeloma: state of art.
Tosi P; Cavo M
Haematologica; 2002 Mar; 87(3):233-4. PubMed ID: 11869932
[No Abstract] [Full Text] [Related]
14. Thalidomide-induced fulminant hepatic failure.
Hamadani M; Benson DM; Copelan EA
Mayo Clin Proc; 2007 May; 82(5):638. PubMed ID: 17493431
[No Abstract] [Full Text] [Related]
15. Severe hypothyroidism after thalidomide treatment.
de Savary N; Lee R; Vaidya B
J R Soc Med; 2004 Sep; 97(9):443. PubMed ID: 15340031
[No Abstract] [Full Text] [Related]
16. Thalidomide treatment for immunoglobulin D multiple myeloma in a patient on chronic hemodialysis.
Hayashi T; Yamaguchi I; Saitoh H; Takagi M; Nonaka Y; Nomura T
Intern Med; 2003 Jul; 42(7):605-8. PubMed ID: 12879955
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolism in patients on thalidomide for myeloma.
Bowcock SJ; Rassam SM; Ward SM; Turner JT; Laffan M
Hematology; 2002 Feb; 7(1):51-3. PubMed ID: 12171777
[TBL] [Abstract][Full Text] [Related]
18. Pneumatosis coli after thalidomide treatment.
Ueki T; Ohashi K; Matsumoto H; Nakajima H; Akiyama H; Sakamaki H
Int J Hematol; 2006 Jun; 83(5):469. PubMed ID: 16787884
[No Abstract] [Full Text] [Related]
19. Thalidomide-induced organizing pneumonia.
Feaver AA; McCune DE; Mysliwiec AG; Mysliwiec V
South Med J; 2006 Nov; 99(11):1292-4. PubMed ID: 17195429
[TBL] [Abstract][Full Text] [Related]
20. Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature.
Martin MG; Vij R
Clin Lymphoma Myeloma; 2009 Aug; 9(4):320-3. PubMed ID: 19717384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
